J M Kirkwood

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

J M Kirkwood, M H Strawderman, Marc S. Ernstoff et al. · Journal of Clinical Oncology · 1996 · 2.1K citations

Medicine, Oncology, Pharmacotherapy +17

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.

Bernard F. Cole, Richard D. Gelber, J M Kirkwood et al. · Journal of Clinical Oncology · 1996 · 205 citations

Pharmacy, Oncology, Pharmacotherapy +17

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

J M Kirkwood, M H Strawderman, Marc S. Ernstoff et al. · Journal of Clinical Oncology · 2023 · 80 citations

Medicine, Oncology, Surgery +17

Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385)

AN Leaf, BC Wolf, J M Kirkwood et al. · Medical Oncology · 2000 · 22 citations

Medicine, Oncology, Pharmacology +7

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Marc S. Ernstoff, William E. Gooding, Suresh Nair et al. · PubMed · 1992 · 21 citations

Life Sciences, Immunology, Oncology +17